Vitamin d mouthwash shows promise for Kids' chalky teeth

NCT ID NCT06515548

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tested whether a vitamin D mouthwash can help repair weak spots on children's permanent teeth (a condition called molar incisor hypomineralization) and improve gum health. Thirty-two children over age 6 used either a vitamin D or placebo mouthwash. Researchers measured tooth strength, plaque buildup, and gum bleeding to see if vitamin D made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

32 people

The number who actually took part.

Started

Aug 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. More than 6 years' child with all permanent incisors and first molar teeth are fully erupted with all surfaces visible. 2. At least one affected first permanent molar were considered to have MIH (Lygidakis et al. 2010; Kühnisch et al. 2014). 3. No chronic systemic disease 4. No acute infection 5. cooperative Child Exclusion Criteria: 1. Drugs (chlorhexidine-based gels and mouthwashes) 2. Hypomineralization with a diameter less than 1 mm. 3. Hypoplastic defects, fluorosis (diffuse hypomineralization), amelogenesis imperfecta, and dentinogenesis imperfecta. 4. Defects on approximal surfaces and diffuse opacities. 5. Fixed orthodontic treatment \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Molar incisor hypomineralization are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amelogenesis imperfecta, type 3A Molar Hypomineralization

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University, Faculty of Dentistry.

    Giza, 12613, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.